Current research does not show that GLP-1 medications directly cause osteoporosis
Because BPC-157 and TB-500 are not approved by the FDA for human use, and are banned by WADA, there are legal, ethical, and safety risks
A 2022 analysis of FDA adverse-event reports, published in Frontiers in Endocrinology , identified 2,670 reported cases of acute kidney injury linked to GLP-1 medicines over an 18-year span
Virtual Consultation Speak with a licensed medical provider
For the resistant strains, FLC and MCFG concentration were 10 g/ml and 1 g/ml respectively
Benefits of BPC 157 Capsules Easy to take with no injection required Convenient for travel or daily use Oral formulations are sometimes discussed in relation to digestive applications, though research is ongoing and evidence in humans is limited